| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6168361 | Urology | 2011 | 4 Pages |
Abstract
Prior fluoroquinolone intake is a significant risk factor behind a rising incidence of acute prostatitis after transrectal prostate biopsy. Identified pathogens are mostly Gram-negative organisms with a high rate of fluoroquinolone resistance. Alternative prophylaxis regimens for the biopsy procedure should be considered in patients with recent quinolone intake.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ashraf A. Mosharafa, Mohamed H. Torky, Wael M. El Said, Alaa Meshref,